Log In
Print this Print this

PF-00489791, PF-489791

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionLong-acting inhibitor of phosphodiesterase-5 (PDE-5)
Molecular Target Phosphodiesterase-5 (PDE-5)
Mechanism of ActionPhosphodiesterase-5 (PDE-5) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetic nephropathy
Indication DetailsTreat diabetic nephropathy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today